Videos

Hollis O’Neal, MD, the national primary investigator for the Cytovale early sepsis detection system, discusses sepsis and COVID-19 and provides an overview of his pilot study.

In part 1 of our interview, Ryan W. Stevens, PharmD, BCIDP, provides an overview of how convalescent plasma has been used to treat infectious diseases including coronaviruses.

Stephen Klasko, MD, MBA, CEO of Thomas Jefferson University Hospitals, discusses what COVID-19 has taught hospitals about preparing for pandemics.

Stephen Klasko, MD, Chief Executive Officer of Thomas Jefferson University Hospitals, discusses the complexity of balancing hospital treatment priorities during the COVID-19 pandemic.

Stephen Klasko, MD, Chief Executive Officer of Thomas Jefferson University Hospitals, discusses the impact of COVID-19 on hospitals around the country.

Lucas Schulz, PharmD, BCPS, AQ-ID, discusses how he is preparing for COVID-19 as a clinical pharmacist working in Wisconsin.

Paul Blair, MD, MHS, MSPH, discusses the needs of frontline health care workers.

Jeannette Bouchard, PharmD, discusses how ID pharmacists are taking on new responsibilities and working collaboratively to respond to COVID-19.

Paul Blair, MD, MHS, MSPH, discusses the changes to everyday life as an ID specialist brought on by COVID-19.

Ramy Elshaboury, PharmD, BCPS, AQ ID, discusses the process of putting COVID-19 guidance in place using currently available literature and data.

Thomas Dilworth, PharmD, shares tips and resources that can help busy clinicians stay engaged and up to date during the COVID-19 pandemic.

Matthew Davis, PharmD, provides an overview on the agent remdesivir.

Thomas Dilworth, PharmD, provides a recap of ACEIs, ARBs, and NSAIDs in patients with COVID-19.

Jason Kindrachuk, PhD, explains the animal reservoir spillover events involved in the emergence of viruses like SARS-CoV-2.

Krutika N. Mediwala, PharmD, BCPS, BCIDP, provides a recap of available information regarding Kaletra for the treatment of COVID-19.

Jason Kindrachuk, PhD, addresses clinician questions about SARS-CoV-2 such as the length of infectious viral shedding and whether the virus will become endemic.

Wendy M. Bamberg, MD, the editor of Contagion®’s Emerging and Re-emerging Infections section, shares her thoughts on social distancing, managing suspect cases, and lessons we can learn about COVID-19.

Jason Kindrachuk, PhD, situates the virus which causes COVID-19 in the context of past coronavirus outbreaks. This is part 1 of a 3-part interview.

Ian Frank, MD, explains the different conceptual understandings of what an HIV cure might entail.

Ian Frank, MD, gives an overview of different HIV vaccine efforts in recent years and on the horizon.

Erin K. McCreary, PharmD, BCPS, BCIDP, discusses emerging literature on potential therapies COVID-19 and how the infectious disease community can work together during this pandemic.

Ian Frank, MD, discusses upcoming treatments for people with HIV.

Tina Q. Tan, MD, discusses vaccine misinformation.

Tina Q. Tan, MD, discusses the particular severity of the ongoing flu season.

Jason Pogue, PharmD, BCPS, BCIDP, shares his thoughts on a study published in the International Journal of Antimicrobial Agents.

Saskia v. Popescu, PhD, MPH, MA, CIC, a senior infection prevention epidemiologist in Phoenix, Arizona, discusses what it’s like for these frontline fighters and what we can do to “flatten the curve.”

Colleen Kelley, MD, MPH, describes what's on the horizon in HIV prevention.

Ian Frank, MD, explains the "Ending the Epidemic" initiative.

Colleen Kelley, MD, MPH, describes the current state of HIV vaccine efforts.

Colleen Kelley, MD, MPH, discusses the importance of targeted youth HIV prevention measures.